XORTX Therapeutics Inc share price logo

XORTX Therapeutics Inc

NASDAQ: XRTX

$1.00

-0.03

(-2.91%)

as on

XORTX Therapeutics Inc Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.95
    $1.11
    downward going graph

    5.00%

    Downside

    11.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.83
    $3.60
    downward going graph

    17.00%

    Downside

    260.00%

    Upside

    downward going graph

XORTX Therapeutics Inc share price movements today

Previous Close
$1.03
Open
$1.03
Volume
244.2K
Market Cap
$4.2M
Day's Low - High
$0.95 - $1.11
52 Week Low - High
$0.83 - $3.60

XORTX Therapeutics Inc Historical Returns

1 Month Return
-39.05 %
3 Month Return
-49.01 %
1 Year Return
-67.24 %
3 Year Return
-92.23 %
5 Year Return
-99.19 %

XORTX Therapeutics Inc Stock Fundamentals & Key Indicators

Check XORTX Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2M

EPS (TTM)

-2.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.97%

PE Ratio (TTM)

-0.38

Industry PE ratio

-2.98

PEG Ratio

0.01

EBITDA

-3.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-138.26%

XORTX Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of XORTX Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
XORTX Therapeutics Inc image
XORTX Therapeutics Inc
Buy$4.2M-99.19%-0.380.00%0.00%
Moderna image
Moderna
Neutral$85.5B-35.47%-26.84-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$134.2B192.00%30.5886.04%0.00%
Regeneron image
Regeneron
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for XORTX Therapeutics Inc Stock including INR - Dollar returns

The XORTX Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

XORTX Therapeutics Inc investment value today

Current value as on today

₹34,033

Returns

-₹65,967

(-65.97%)

Returns from XORTX Therapeutics Inc Stock

-₹68,198 (-68.2%)

Dollar Impact

₹2,232 (+2.23%)

Analyst Recommendation on XORTX Therapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for XORTX Therapeutics Inc. Average target price of $14.04

XORTX Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on XORTX Therapeutics Inc.

What analysts predicted

92.88%UPSIDE

Target Price

$14.04

Current Price

$1

Analyzed by

5 Analysts

Target

$14.04

XORTX Therapeutics Inc target price $14.04, a slight upside of 92.88% compared to current price of $1. According to 5 analysts rating.

Indian Investors' Interest in XORTX Therapeutics Inc Stock

Search interest for XORTX Therapeutics Inc Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:38% versus previous 30 day period

XORTX Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
-
-
0
-
-
Operating Income
-1
-1
0
0
0
0
0
0
0
-1
EBITDA
-1
-1
0
0
0
0
0
0
0
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
0
0
0
0
0
0
0
0
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
0
0
0
0
0
0
0
0
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

XORTX Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Mar 2021
Mar 2023
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
-
0
-
Operating Income
0
-1
0
-1
-12
-6
-3
-3
EBITDA
0
-1
0
-1
-12
-5
-3
-3
Interest Expense
0
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
0
-3
0
-1
-10
-2
-3
-2
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
0
-3
0
-1
-10
-2
-3
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

XORTX Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
0
0
0
0
0
0
0
0
-1
Operating Cash Flow
-1
0
0
0
0
0
0
0
0
-3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
1
0
0
1
0
0
0
0
0
4
Change in Cash
0
0
0
0
0
0
0
0
0
0

XORTX Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Dec 2024
Dec 2025
Net Income
0
-3
0
-1
-1
-7
-2
-3
-2
Operating Cash Flow
0
0
0
0
-4
-8
-6
-3
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
1
0
0
19
3
0
2
1
Change in Cash
0
0
0
0
14
-4
-6
0
-1

Global Institutional Holdings in XORTX Therapeutics Inc

Check out the Institutions with significant holdings in XORTX Therapeutics Inc.

Funds
Holdings
Armistice Capital, LLC
0.00%
Baader Bank INC
0.00%
Hartland & Co
0.02%
Advisor Group Holdings, Inc.
0.00%
NATIONAL BANK OF CANADA /FI/
0.01%
See all

XORTX Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 08 October

    Fri, 01:35 AM

    -

    XORTX Therapeutics outlines clinical trial application for XRx-026 gout program to Health Canada, supporting FDA NDA filing.

Insights on XORTX Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, XRTX stock has moved up by 11.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 786.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 192.3% return, outperforming this stock by 285.0%

About XORTX Therapeutics Inc

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kidney disease (ADPKD). Another key candidate is XRx-101, an agent aimed at reducing uric acid levels in COVID-19 patients, with the goal of mitigating acute kidney injury and related complications. Furthermore, they are developing XRx-221, a series of xanthine oxidase inhibitors intended for the management of diabetic nephropathy. XORTX also collaborates with the Icahn School of Medicine on research investigating acute kidney injury and hyperuricemia among hospitalized COVID-19 patients. The company's operations are headquartered in Vancouver, Canada.
OrganisationXORTX Therapeutics Inc
Headquarters3710 - 33rd Street NW, Calgary, AB, T2L 2M1, CA
IndustryBiotechnology
CEOAllen Warren Davidoff

Key Management of XORTX Therapeutics Inc

Name

Title

Dr. Allen Warren Davidoff Ph.D.

Founder, Co-CEO, President & Director

Nick Rigopulos

Director of Communications

Dr. David MacDonald Ph.D.

Consultant of Clinical Operations

Dr. Michael Scott Bumby D.V.M., M.B.A.

Chief Financial Officer

Dr. Stephen Haworth M.D., MRCP

Chief Medical Officer

Dr. Stacy Evans M.B.A., M.D.

Chief Business Officer

Mr. Mika Grasso

Co-CEO & Director

Dr. David Sans M.B.A., Ph.D.

Director of Corporate Development

Ms. Charlotte May

Corporate Secretary

FAQs

What is XORTX Therapeutics Inc share price today?

XORTX Therapeutics Inc share price today is $1.00 as on at the close of the market. XORTX Therapeutics Inc share today touched a day high of $1.11 and a low of $0.95.

What is the 52 week high and 52 week low for XORTX Therapeutics Inc share?

XORTX Therapeutics Inc share touched a 52 week high of $3.60 on and a 52 week low of $0.83 on . XORTX Therapeutics Inc stock price today i.e. is closed at $1.00,which is 72.22% down from its 52 week high and 20.48% up from its 52 week low.

What is XORTX Therapeutics Inc's market capitalisation today?

XORTX Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in XORTX Therapeutics Inc Stock (XRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for XORTX Therapeutics Inc on INDmoney app. Click on Buy button.

What is the minimum amount required to buy XORTX Therapeutics Inc Stock (XRTX) from India?

Indian investors can start investing in XORTX Therapeutics Inc (XRTX) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in XORTX Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on XORTX Therapeutics Inc share’s latest price of $1.00 as on October 31, 2026 at 8:46 am IST, you will get 10.0000 shares of XORTX Therapeutics Inc. Learn more about fractional shares .

What are the returns that XORTX Therapeutics Inc has given to Indian investors in the last 5 years?

XORTX Therapeutics Inc stock has given -99.19% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?